Heart rate control is associated with reduced cardiovascular events in Asian patients with coronary artery disease treated with bisoprolol (BISO-CAD): results from a multi-national, real-world experience

Yundai ChenDepartment of Cardiology, China PLA General Hospital, Beijing, China; Correspondence[email protected]

Xinchun YangDepartment of Cardiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China;

Vinh Nguyen PhamDepartment of Cardiology, Tam Duc Hospital, Vietnam;

Shian HuangDepartment of Cardiology, Affiliated Hospital of Guangdong Medical College, Guangdong, China;

Guosheng FuDepartment of Cardiology, Sir Run Shaw Hospital, Affiliated with School of Medicine Zhejiang University, Zhejiang, China;

Xiaoping ChenDepartment of Cardiology, West China Hospital, Sichuan, China;

Binh Quang TruongDepartment of Cardiology, University Medical Centre HCMC, Vietnam;

Yu YangGeriatrics Department, The Second Xiangya Hospital of Central South University, Changsha, China;

Shaowen LiuDepartment of Cardiology, Shanghai First People’s Hospital, Shanghai, China;

Xuan ChenDepartment of Medical Affairs, Merck Serono Co. Ltd., Beijing, China;

Tianrong MaDepartment of Medical Affairs, Merck Serono Co. Ltd., Beijing, China;

Dong-Soo KimDepartment of Cardiology, Inje University Busan Paik Hospital, Busan, Korea;

Tae-hoon KimDepartment of Cardiology, Sejong Hospital, Gyeonggi-do, Korea; ;Department of Cardiology, New Korea Hospital, Gyeonggi-do, Korea

Related Research Data